Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $337.55 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $56.50 | 4 | $0 (2022) |
| Boston Scientific Corporation | $49.52 | 3 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $35.34 | 2 | $0 (2022) |
| Allergan Inc. | $26.84 | 2 | $0 (2017) |
| Lilly USA, LLC | $25.47 | 2 | $0 (2017) |
| Takeda Pharmaceuticals America, Inc. | $21.66 | 1 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $21.03 | 1 | $0 (2020) |
| PFIZER INC. | $19.88 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.41 | 1 | $0 (2017) |
| Ironwood Pharmaceuticals, Inc | $17.20 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $84.78 | 5 | Boston Scientific Corporation ($35.48) |
| 2021 | $30.03 | 2 | AbbVie Inc. ($16.38) |
| 2020 | $21.03 | 1 | Teva Pharmaceuticals USA, Inc. ($21.03) |
| 2019 | $26.13 | 2 | Boston Scientific Corporation ($14.04) |
| 2017 | $175.58 | 11 | AstraZeneca Pharmaceuticals LP ($30.57) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: General - Pain Management_NMD | ||||||
| 07/20/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/08/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/04/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: RESPIRATORY | ||||||
| 04/26/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/15/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Diabetes | ||||||
| 04/27/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Central Nervous System | ||||||
| 09/18/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/23/2019 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/12/2017 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/22/2017 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/14/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: DIABETES | ||||||
| 06/07/2017 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Diabetes | ||||||
| 05/08/2017 | PFIZER INC. | VIAGRA (Drug), LYRICA | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 05/04/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/09/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: DIABETES | ||||||
| 03/08/2017 | Ironwood Pharmaceuticals, Inc | LINZESS (Drug), VIBERZI, ZURAMPIC | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Gastroenterology | ||||||
| 03/02/2017 | Lilly USA, LLC | HUMALOG (Drug), TRADJENTA, TRULICITY | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Diabetes | ||||||
| 02/27/2017 | Takeda Pharmaceuticals America, Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Lower GI | ||||||
| 02/09/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 12 | 877 | 1,085 | $138,874 | $46,225 |
| 2021 | 18 | 1,679 | 2,449 | $298,204 | $112,725 |
| 2020 | 13 | 1,173 | 1,485 | $203,337 | $64,935 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 258 | $60,114 | $18,652 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 101 | 101 | $24,846 | $12,139 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 144 | 205 | $32,390 | $9,438 | 29.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 48 | 49 | $4,655 | $1,284 | 27.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 71 | 71 | $2,840 | $1,198 | 42.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 77 | 112 | $3,808 | $1,078 | 28.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 56 | 56 | $2,240 | $962.86 | 43.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 29 | 29 | $3,973 | $341.75 | 8.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $1,023 | $309.61 | 30.3% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 14 | 24 | $1,554 | $299.83 | 19.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 90 | 90 | $720.00 | $264.53 | 36.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 61 | 79 | $711.00 | $256.92 | 36.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 258 | 564 | $131,412 | $43,882 | 33.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 207 | 372 | $58,776 | $19,055 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 144 | 144 | $35,424 | $17,885 | 50.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 89 | 110 | $10,450 | $5,645 | 54.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 54 | 63 | $8,631 | $5,190 | 60.1% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 17 | 18 | $8,982 | $3,752 | 41.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 22 | 22 | $8,140 | $3,483 | 42.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 144 | 144 | $5,760 | $2,457 | 42.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 128 | 253 | $8,602 | $2,457 | 28.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 125 | 125 | $5,000 | $2,133 | 42.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 29 | 29 | $6,757 | $1,815 | 26.9% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 81 | 85 | $1,700 | $1,685 | 99.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 85 | 89 | $2,581 | $1,360 | 52.7% |
About Dr. Barbara Smith, MD
Dr. Barbara Smith, MD is a Family Medicine healthcare provider based in Natchez, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730187261.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Smith, MD has received a total of $337.55 in payments from pharmaceutical and medical device companies, with $84.78 received in 2022. These payments were reported across 21 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($337.55).
As a Medicare-enrolled provider, Smith has provided services to 3,729 Medicare beneficiaries, totaling 5,019 services with total Medicare billing of $223,885. Data is available for 3 years (2020–2022), covering 43 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Natchez, MS
- Active Since 07/08/2005
- Last Updated 08/12/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730187261
Products in Payments
- FARXIGA (Drug) $56.50
- General - Pain Management (Device) $35.48
- JARDIANCE (Drug) $30.88
- BYSTOLIC (Drug) $26.84
- Amitiza (Drug) $21.66
- AJOVY (Biological) $21.03
- VIAGRA (Drug) $19.88
- SOLIQUA 100/33 (Biological) $19.79
- LINZESS (Drug) $17.20
- UBRELVY (Drug) $16.38
- TRELEGY ELLIPTA (Drug) $15.67
- TOUJEO (Drug) $15.55
- GENERAL PAIN MANAGEMENT (Device) $14.04
- Ozempic (Drug) $13.65
- HUMALOG (Drug) $13.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Natchez
Scott Wolfe, M.d, M.D
Family Medicine — Payments: $11,448
Jose Serio, Fnp, FNP
Family Medicine — Payments: $739.76
Jeffrey Anderson, D.o, D.O
Family Medicine — Payments: $554.12
Dr. Matthew Verucchi, Md, MD
Family Medicine
Dr. Frederick Ragan, Md, MD
Family Medicine